Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
carbapenem |
| gptkbp:activeIngredient |
gptkb:tebipenem
|
| gptkbp:affiliatedWith |
gptkb:beta-lactam_antibiotics
|
| gptkbp:approvedBy |
gptkb:Japan
2009 pediatric use |
| gptkbp:ATCCode |
J01DH08
|
| gptkbp:CASNumber |
186034-35-3
|
| gptkbp:developedBy |
gptkb:Meiji_Seika_Pharma
|
| gptkbp:formulationOf |
gptkb:tebipenem
|
| gptkbp:hasMolecularFormula |
C15H17N3O5S2·HBr
|
| gptkbp:hasSaltForm |
hydrobromide
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tebipenem HBr
|
| gptkbp:indication |
gptkb:sinusitis
urinary tract infections otitis media respiratory tract infections |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Orapenem
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea rash |
| gptkbp:spectrumOfActivity |
broad-spectrum
|
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:Spero_Therapeutics
|
| gptkbp:bfsLayer |
7
|